Docusate Sodium
Active substance: docusate
CAPSULE, LIQUID FILLED · DOCUSATE SODIUM 250 mg/1
United StatesActive
Marketing holder: Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- DOCUSATE SODIUM · 250 mg/1
Registration
- Registration number
- 53345-035
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- ORAL
Sources
- product · openFDA NDC · 53345-035 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 53345-035 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 53345-035 · Verified 2026-10-09 · open in source